首页> 外文期刊>Current neuropharmacology >Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression
【24h】

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression

机译:抑郁症的病理机制和药物治疗机制研究

获取原文
获取外文期刊封面目录资料

摘要

Depression is one of the prevalent and persistent psychiatric illnesses. It brings heavy socioeconomic burden such as healthcare expenditures and even higher suicide rates. Despite many hypotheses about its mechanism have been put forward, so far it is still unclear, not to mention the precise and effective diagnostic or therapeutic methods. In this paper, the current conditions of pathological and pharmacological mechanism of depression were reviewed systematically. Firstly, the most recent hypotheses and metabolomics based research including hereditary, neurotransmitter systems, brain derived neurotrophic factor (BDNF), hyperactivity of the hypothalamic pituitary adrenal (HPA) axis and inflammatory as well as metabolomics were summarized. Secondly, the present situation and development on antidepressant drugs at home and abroad were reviewed. Finally, a conclusion and prospect on the pathological and pharmacological mechanism of depression were provided primarily.
机译:抑郁症是一种普遍存在的精神疾病。它带来沉重的社会经济负担,例如医疗保健支出,甚至更高的自杀率。尽管已经提出了许多关于其机制的假设,但是到目前为止,还不清楚,更不用说精确有效的诊断或治疗方法了。本文对抑郁症的病理,药理机制现状进行了系统综述。首先,总结了基于遗传学,神经递质系统,脑源性神经营养因子(BDNF),下丘脑垂体肾上腺(HPA)轴活动亢进以及炎症和代谢组学的最新假设和代谢组学研究。其次,综述了国内外抗抑郁药的现状与发展。最后,主要为抑郁症的病理和药理机制提供了结论和展望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号